How long does semaglutide titration take?

Wegovy titration to 2.4 mg maintenance takes 16 weeks (reached at week 17). Ozempic typically reaches its 1.0 mg maintenance dose at week 9. Titration is deliberately slow to reduce GI side effects.

Can I go faster through titration?

Faster escalation is associated with higher rates of nausea, vomiting, and discontinuation. The FDA label is specific: 4 weeks at each step. Some patients need to go slower, not faster.

Can I stay at a lower dose?

Yes. FDA guidance allows Wegovy maintenance at 1.7 mg weekly (or even lower) if the full 2.4 mg is not tolerated. Efficacy is reduced but clinically meaningful. Discuss with your prescriber.

Wegovy Titration Schedule Builder

Pick your medication and start date. We'll generate a week-by-week calendar showing every dose from escalation through maintenance — based on the current FDA prescribing information^{[FDA PI]}.

Medication

Start date

Current dose (optional)

What to expect at each step

Escalation weeks (low doses)

The first 8 weeks of titration are intentionally below therapeutic levels. The goal is acclimation, not weight loss. Many patients see modest appetite changes starting at the 0.25 mg step, but meaningful changes usually appear once the dose reaches 1.0 mg or above. Expect mild nausea, occasional loose stools, and some fatigue — these typically fade within the first 10 days of each step.

Mid-titration (1.0 – 1.7 mg)

This is the inflection point for most patients. Appetite suppression becomes noticeable, portion sizes drop, and weight loss accelerates. Side effects may re-emerge briefly after each step-up; if nausea becomes disruptive, talk to your prescriber about holding at 1.0 or 1.7 mg for an extra month.

Maintenance (2.4 mg)

The full 2.4 mg dose is what drove the STEP-1 trial's ~15% average weight loss¹. Expect continued but slower progress from month 5 onward, reaching plateau around month 12–15. Side effects are usually well tolerated by this point. Staying on maintenance dose long-term is standard — discontinuation typically leads to weight regain within 12 months per the STEP-4 extension trial².

Tip: Log each injection day and any side effects in a notes app. When your prescriber asks how titration went, you'll have a real timeline — not a guess.

References

Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. PubMed 33567185
Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA 2021. PubMed 35015037
Wegovy (semaglutide) FDA prescribing information, Section 2.2 (titration schedule). FDA label PDF · Drugs@FDA overview
Ozempic (semaglutide) FDA prescribing information, Section 2.1 (dosage escalation). FDA label PDF
Rybelsus (oral semaglutide) FDA prescribing information, Section 2.2. FDA label PDF